Galmed Pharmaceuticals (GLMD) News Today → Wall Street Icon: 'I'd Put 50% of My Kids' Inheritance in THIS stock' (From Stansberry Research) (Ad) Free GLMD Stock Alerts $0.35 0.00 (0.00%) (As of 06/11/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 11 at 4:20 AM | americanbankingnews.comGalmed Pharmaceuticals (NASDAQ:GLMD) Now Covered by Analysts at StockNews.comJune 3, 2024 | americanbankingnews.comGalmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Short Interest Down 13.1% in MayApril 13, 2024 | fool.comGalmed Pharmaceuticals (NASDAQ: GLMD)April 10, 2024 | investorplace.comWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024April 4, 2024 | prnewswire.comGalmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023March 15, 2024 | markets.businessinsider.comGalmed Granted European Patent For Use Of Aramchol-Resmetirom To Treat NASH/MASH, Liver FibrosisMarch 15, 2024 | prnewswire.comGalmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver FibrosisFebruary 13, 2024 | uk.finance.yahoo.comGalmed Pharmaceuticals Ltd (GPH.BE)January 3, 2024 | uk.finance.yahoo.comGalmed Pharmaceuticals Ltd. (GPH.F)November 20, 2023 | finance.yahoo.comGalmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a StudyNovember 4, 2023 | morningstar.comGalmed Pharmaceuticals Ltd GLMDSeptember 26, 2023 | finance.yahoo.comGalmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal FibrosisAugust 3, 2023 | nasdaq.comGalmed Pharmaceuticals (GLMD) Price Target Increased by 300.00% to 4.08July 14, 2023 | marketwatch.comGalmed Pharma Shares Drop 30% After Public Offering PricesJuly 14, 2023 | seekingalpha.comGalmed shares slump on pricing discounted stock and warrants offeringJuly 14, 2023 | finance.yahoo.comGalmed Pharmaceuticals Announces Pricing of $7 Million Public OfferingJuly 14, 2023 | marketbeat.comTrading was temporarily halted for "GLMD" at 09:07 AM with a stated reason of "LULD pause."July 13, 2023 | investorplace.comWhy Is Galmed Pharmaceuticals (GLMD) Stock Moving Today?July 12, 2023 | marketbeat.comTrading was temporarily halted for "GLMD" at 12:07 PM with a stated reason of "LULD pause." Trading set to resume at 12:07 PM. July 12, 2023 | marketbeat.comTrading was temporarily halted for "GLMD" at 12:07 PM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comTrading was temporarily halted for "GLMD" at 12:07 PM with a stated reason of "LULD pause."July 10, 2023 | finance.yahoo.comGalmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSCJuly 3, 2023 | bizjournals.comMadrigal begins process seeking OK for multibillion-dollar — yet elusive — NASH drugJune 3, 2023 | benzinga.comGalmed Pharmaceuticals Stock (NASDAQ:GLMD), Insider Trading ActivityJune 1, 2023 | finanznachrichten.deGalmed Pharmaceuticals Ltd.: Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent DevelopmentsJune 1, 2023 | msn.comRecap: Galmed Pharmaceuticals Q1 EarningsJune 1, 2023 | finance.yahoo.comGalmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent DevelopmentsMay 17, 2023 | thestreet.comWhy Galmed Pharmaceuticals (GLMD) Stock Is Surging TodayMay 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Galmed Pharmaceuticals (GLMD) and Haemonetics (HAE)May 9, 2023 | finance.yahoo.comGalmed Announces Initiation of a Clinical Development Program to Evaluate Aramchol meglumine for the Treatment of Primary Sclerosing Cholangitis (PSC)May 5, 2023 | msn.comWhy Is Galmed Pharmaceuticals (GLMD) Stock Up 37% Today?May 4, 2023 | finance.yahoo.comGalmed Pharmaceuticals forms a Strategic Partnership with OnKaiMarch 29, 2023 | finance.yahoo.comGalmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022February 17, 2023 | seekingalpha.comGLMD Galmed Pharmaceuticals Ltd.February 8, 2023 | finance.yahoo.comGalmed Announces Issuance of New Composition of Matter Patent for Aramchol meglumine SaltJanuary 6, 2023 | finance.yahoo.comCan Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?January 4, 2023 | marketwatch.comGalmed Pharmaceuticals Shares Up 9.2% on Data From Liver Treatment Aramchol StudyJanuary 4, 2023 | finance.yahoo.comGalmed reports results from the Open-Label part of the ARMOR study showing improvements in histology, imaging, and biomarkers with AramcholDecember 14, 2022 | finance.yahoo.comGalmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price RequirementSeptember 14, 2022 | finance.yahoo.comGalmed Pharmaceuticals (GLMD) Moves to Buy: Rationale Behind the UpgradeAugust 4, 2022 | finance.yahoo.comGalmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial ResultsJuly 7, 2022 | finance.yahoo.comGalmed's Aramchol Shows Anti-Fibrotic Effects In Lung Fibrosis Animal ModelJuly 7, 2022 | nasdaq.comGalmed: New Data Reinforces Expansion Of Aramchol's Clinical Development To Additional IndicationsJuly 7, 2022 | finance.yahoo.comGalmed Reports Significant Anti-Fibrotic Effects of Aramchol in a Lung Fibrosis ModelJune 17, 2022 | finance.yahoo.comGalmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price NotificationMay 25, 2022 | benzinga.comGalmed Pharmaceuticals (NASDAQ:GLMD), Analyst Ratings, Price Targets, PredictionsMay 18, 2022 | seekingalpha.comGalmed Pharmaceuticals shares fall after downgrade by Raymond James analystMay 17, 2022 | finance.yahoo.comGalmed updates business and clinical development strategy to better leverage Aramchol's anti-fibrotic effectsMay 17, 2022 | finance.yahoo.comGalmed Pharmaceuticals Reports First Quarter 2022 Financial ResultsMay 3, 2022 | marketwatch.comGalmed Pharmaceuticals Shares Down 16% Get Galmed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for GLMD and its competitors with MarketBeat's FREE daily newsletter. Email Address The Hidden Tax Advantages of America’s #1 Inheritance Stock (Ad)Wall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $0.35, AMZN under $2.50, and NVDA before it soared 1,200%. Recently, he sat down for an exclusive interview, revealing EXACTLY where to put your money this year. An investment vehicle he's so confident in, he says he'd put 50% of his kids' inheritance into this stock. You can get the name and ticker symbol, absolutely free, right here. GLMD Media Mentions By Week GLMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLMD News Sentiment▼0.000.92▲Average Medical News Sentiment GLMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLMD Articles This Week▼20▲GLMD Articles Average Week Get Galmed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for GLMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PULM News Today CYCN News Today ASLN News Today TENX News Today LGVN News Today EFTR News Today GRTX News Today XBIO News Today HEPA News Today ENVB News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GLMD) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored